Expanded hemodialysis as effective alternative to on-line hemodiafiltration: A randomized mid-term clinical trial.

When evaluating subjects who completed the 24‐week study period, those in the HDF study arm ( N = 12) showed stable mean weekly dose of ESA over time (baseline: 99 ± 74 IU/kg, week 12: 113 ± 75 IU/kg, week 24: 102 ± 74 IU/kg) while the HDx study arm subjects ( N = 19) showed a trend toward a decrease in weekly ESA dose from week 8 (baseline: 106 ± 87 IU/kg, week 12: 98 ± 102 IU/kg, week 24: 77 ± 103 IU/kg) (Figure 2a ).

also in 53,322 other papers